Prevalence of Delayed Chemotherapy Associated Nausea
מילות מפתח
תַקצִיר
תיאור
Chemotherapies are rated to have a high to minimal emetogenic potential in oncology patients. Their potential to induce delayed nausea is supposed to often be higher than their emetogenic potential. However, data on delayed chemotherapy-related nausea are scarce, which is problematic because nausea (a) has a large impact on patients quality of life and treatment decisions, (b) is often underestimated by health care professionals, (c) is less responsive to commonly used antiemetic medication, and (d) may even be different from rates that have been established in controlled clinical trials.
Therefore, the aim of this study is to assess the prevalence of delayed chemotherappy-induced nausea in adult oncology patients in dayclinics.
תאריכים
| אומת לאחרונה: | 03/31/2020 |
| הוגש לראשונה: | 03/24/2020 |
| ההרשמה המשוערת הוגשה: | 04/08/2020 |
| פורסם לראשונה: | 04/12/2020 |
| העדכון האחרון הוגש: | 04/19/2020 |
| עדכון אחרון פורסם: | 04/21/2020 |
| תאריך תחילת לימוד בפועל: | 06/28/2020 |
| תאריך סיום משוער משוער: | 12/30/2021 |
| תאריך סיום משוער ללימודים: | 04/30/2022 |
מצב או מחלה
שלב
קריטריונים לזכאות
| גילאים הזכאים ללימודים | 18 Years ל 18 Years |
| מינים הזכאים ללימודים | All |
| שיטת דגימה | Non-Probability Sample |
| מקבל מתנדבים בריאים | כן |
| קריטריונים | Inclusion Criteria: - first day of chemotherapy of a new cycle (any cycle) - speak and write German - sign the consent forms Exclusion Criteria: - cognitive or linguistic impairments that would significantly impede consent or participation (as assessed by the nurses in charge) - accompanying radiotherapy; - pre-existing nausea within three days before the start of the first chemotherapy in this cycle; and - prior participation in CINrate (each person participates only once) |
תוֹצָאָה
מדדי תוצאות ראשוניים
1. delayed Nausea [Each patient: each days for 5 days after chemotherapy; recruitment: six weeks]
אמצעי תוצאה משניים
1. acute nausea [Each patient: at day of chemotherapy at discharge from dayclinic; recruitment: six weeks]
2. acute and delayed vomiting [Each patient: each day for 5 days after chemotherapy; recruitment: six weeks]
3. adherence to antiemetics [Each patient: each day for 5 days after chemotherapy; recruitment: six weeks]
4. antiemetic prescription [Each patient: at day of chemotherapy at discharge from dayclinic; recruitment: six weeks]
5. interference of nausea or vomiting with everyday life [Each patient: measured at day 5 after chemotherapy; recruitment: six weeks]
6. patient-related barriers to antiemetics [Each patient: measured at day 5 after chemotherapy; recruitment: six weeks]
